PT Famon Awal Bros Sedaya Tbk

Jakarta Stock Exchange PRAY.JK

PT Famon Awal Bros Sedaya Tbk Shareholders' Equity for the year ending December 31, 2023: USD 181.90 M

PT Famon Awal Bros Sedaya Tbk Shareholders' Equity is USD 181.90 M for the year ending December 31, 2023, a 9.82% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • PT Famon Awal Bros Sedaya Tbk Shareholders' Equity for the year ending December 31, 2022 was USD 165.64 M, a 36.78% change year over year.
  • PT Famon Awal Bros Sedaya Tbk Shareholders' Equity for the year ending December 31, 2021 was USD 121.10 M, a 24.67% change year over year.
  • PT Famon Awal Bros Sedaya Tbk Shareholders' Equity for the year ending December 31, 2020 was USD 97.14 M, a 22.23% change year over year.
  • PT Famon Awal Bros Sedaya Tbk Shareholders' Equity for the year ending December 31, 2019 was USD 79.47 M.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
SV Wall Street
Jakarta Stock Exchange: PRAY.JK

PT Famon Awal Bros Sedaya Tbk

CEO Engineer Arfan Awaloeddin
IPO Date Nov. 8, 2022
Location Indonesia
Headquarters Jl. Ruko Mega Grosir Cempaka Mas Blok N/21
Employees 5,749
Sector Healthcare
Industries
Telehealth Dental Care Hospitals & Clinics Personal Care
Description

PT Famon Awal Bros Sedaya Tbk operates a network of hospitals in Indonesia. The company provides cardiac and vascular, orthopedic sport clinic, trauma center, heart and blood vessel, cancer center, brain and neuro center, eye center, oncology, mother and child, and urology services. It also offers clinical laboratory service, homecare, and medical evacuation, as well as other various health care and online consultation services. PT Famon Awal Bros Sedaya Tbk was founded in 1997 and is based in Kemayoran, Indonesia. PT Famon Awal Bros Sedaya Tbk is a subsidiary of PT Famon Obor Maju.

StockViz Staff

February 4, 2025

Any question? Send us an email